IRF
SRPT icon

IBM Retirement Fund’s Sarepta Therapeutics SRPT Stock Holding History

IBM Retirement Fund’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,181
Closed -$202K – 686
2021
Q3 		$202K Buy
+2,181
New +$168K 0.02% 730
2021
Q1 		– Sell
-2,750
Closed -$469K – 792
2020
Q4 		$469K Buy
2,750
+332
+14% +$49.2K 0.03% 472
2020
Q3 		$340K Buy
2,418
+679
+39% +$103K 0.03% 489
2020
Q2 		$279K Buy
+1,739
New +$237K 0.04% 418

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

IBM Retirement Fund's SRPT Position: Q4 2021 in Review

IBM Retirement Fund sold out of Sarepta Therapeutics (SRPT) in Q4 2021, closing a stake of 2,181 shares — an estimated $202K sold.

IBM Retirement Fund first reported a position in SRPT in Q2 2020 and held it in 4 quarters. The position peaked at $469K in Q4 2020. 343 funds tracked by Wall St. Rank hold SRPT as of Q4 2021.

  • IBM Retirement Fund reported no remaining Sarepta Therapeutics position as of Q4 2021 after selling out during the quarter.
  • IBM Retirement Fund sold 2,181 Sarepta Therapeutics shares in Q4 2021, an estimated $202K.
  • IBM Retirement Fund first reported a position in Sarepta Therapeutics in Q2 2020 and held it in 4 quarters.
  • IBM Retirement Fund's Sarepta Therapeutics position peaked at $469K in Q4 2020.
  • 343 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2021.

Based on IBM Retirement Fund's 13F filing for Q4 2021, filed 19 Jan 2022.